Dr. Coors Treats First Patient in DAYBREAK Clinical Trial of Intravitreal Tarcocimab Tedromer and Tabirafusp Tedromer for Wet AMD
Texas Retina’s Lori E. Coors, MD, recently enrolled and treated the first patient in the Phase III DAYBREAK trial evaluating an intravitreal tarcocimab tedromer and tabirafusp tedromer compared with intravitreal aflibercept in
read more
Celebrating Family Caregivers
November is National Family Caregivers Month. At Texas Retina, we recognize and thank all of the humble, unsung heroes who selflessly give of their own time and energy to care for family
read more
Happy Veterans Day!
On behalf of everyone at Texas Retina, we would like to extend our deepest gratitude for the sacrifices that our service members, both past and present, have made for our country.
read more
New Wichita Falls Office is Open!
We’re excited to announce that our new, larger Wichita Falls office is officially open! All of our Wichita Falls physicians — Gary Edd Fish, MD; Wayne A. Solley, MD; Andrew J. McClellan,
read more
Dr. Abbey Presented at the Outpatient Ophthalmic Surgery Society (OOSS) Symposium 2024
Texas Retina’s Ashkan Abbey, MD, recently presented “Innovation in Retina for the ASC” at the Outpatient Ophthalmic Surgery Society (OOSS) Symposium 2024. He highlighted the advantages and disadvantages of several recent surgical
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood vessels all over the body, including
read more
Texas Retina’s New Wichita Falls Office Opening November 7!
We’re excited to announce that our new, larger Wichita Falls office will officially open on November 7, 2024! This new office will replace our current Wichita Falls office and at 7,500 square
read more
Dr. Abbey Doses First Patient in Phase III LUGANO Clinical Trial of Duravyu for Wet AMD
Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, recently dosed the first patient in the Phase III LUGANO clinical trial of Duravyu (formerly EYP-1901) for the treatment of
read more
What to Expect From an Eye Injection
We know the idea of having an injection in your eye can sound scary, but for many retinal diseases, it is the only way we can deliver potentially sight-saving medicine where it
read more
Dr. Abbey Taught a Course at the American Academy of Ophthalmology 2024 Annual Meeting
For the fifth year, Texas Retina’s Ashkan M. Abbey, MD, taught a continuing medical education (CME) course titled, “Secondary IOL Techniques for Retinal Specialists,” at the annual meeting of the American Academy
read more